Importantly, the two vanadium compounds, bis(acetylacetonato)-oxidovanadium(IV) and sodium metavanadate, inhibit cell proliferation via ROS-induced activation of both PI3K/AKT and MAPK/ERK signaling pathways in human pancreatic cancer AsPC-1 cells [29]. Here, AKT1 is linked to pancreatic neoplasm.